648869-66-3Relevant academic research and scientific papers
Design of concise, scalable route to a cholecystokinin 1 (CCK 1) receptor antagonist
Liang, Jimmy T.,Mani, Neelakandha S.,Jones, Todd K.
, p. 8243 - 8250 (2008/03/11)
(Chemical Equation Presented) Development of efficient, scalable routes for the synthesis of (S)-3-[5-(3,4-dichlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol- 3-yl]-2-m-tolyl propionic acid, a selective cholecystokinin 1 (CCK 1) receptor antagonist, is descri
Pyrazole CCK1 receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity
McClure, Kelly,Hack, Michael,Huang, Liming,Sehon, Clark,Morton, Magda,Li, Lina,Barrett, Terrance D.,Shankley, Nigel,Breitenbucher, J. Guy
, p. 72 - 76 (2007/10/03)
High throughput screening revealed compound 1 as a potent antagonist of the CCK1 receptor. Evaluation of the CCK1 SAR in a series of these diarylpyrazole antagonists was conducted in a matrix synthesis format revealing additive (Free
CCK-1 RECEPTOR MODULATORS
-
Page/Page column 245-246, (2010/02/10)
There are provided by the present invention certain pyrazole based CCK-1 receptor modulators which have the general formula: (I) wherein Ar is an aromatic or heteroaromatic group, X is a hydrocarbon linker, Y is a bond or hydrocarbon linker and R1, R2, R3, R4 and R5 are certain organic substituents, and methods of making the same.
